A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Pfizer
Pfizer
Tizona Therapeutics, Inc
Takeda
Kidney Cancer Research Bureau
Second Life Therapeutics
Novartis
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
A2 Biotherapeutics Inc.
Washington University School of Medicine
Genentech, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Cancer Research UK
DEKA Biosciences
Columbia University
Elevation Oncology
Rutgers, The State University of New Jersey
Universidade Federal de Pernambuco
Inhibrx Biosciences, Inc
European Organisation for Research and Treatment of Cancer - EORTC
Washington University School of Medicine
Cedars-Sinai Medical Center
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Kineta Inc.
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Imperial College London
Roswell Park Cancer Institute
Pfizer
Weill Medical College of Cornell University
Hospices Civils de Lyon
Sun Yat-sen University
Celgene
Osaka University
Instituto do Cancer do Estado de São Paulo
Stanford University
Amgen
Celldex Therapeutics
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Roswell Park Cancer Institute
Santa Maria Biotherapeutics
Dana-Farber Cancer Institute
Fox Chase Cancer Center